3.25 USD
↗ 0.02 (0.46%)LIVE (AS OF 02:24 PM EDT)
Altimmune, Inc. Common Stock
ALTNASDAQ • USD
Market: OPEN
Shares of Altimmune, Inc. Common Stock (ALT) are trading at $3.25. The technical outlook is "Neutral" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ALT at a fair price relative to peers.
Technical & fundamental data as of Sep 15, 2026.
Open?$3.27
High?$3.29
Low?$3.21
Prev. Close?$3.23
Volume?1.7M
Avg. Volume?4.1M
VWAP?$3.24
Rel. Volume?0.43x
Bid / Ask
Bid?$3.25 × 11.5K
Ask?$3.26 × 8.6K
Spread?$0.01
Midpoint?$3.26
Valuation & Ratios
Market Cap?628.3M
Shares Out?194.5M
Float?177.1M
Float %?91.1%
P/E Ratio?N/A
P/B Ratio?1.32
EPS?-$0.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Employees
57
Market Cap
628.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2005-10-06
Address
910 CLOPPER ROAD
GAITHERSBURG, MD 20878
Phone: (240) 654-1450
GAITHERSBURG, MD 20878
Phone: (240) 654-1450
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?77
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?5.37Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?28.07%Squeeze Risk
Short Interest?49.7M
Days to Cover?11.8
Free Float177.1M
Avg Daily Volume4.2M
Settlement Date2026-08-31
Financial Health
Current Ratio?26.78Strong
Quick Ratio?26.78Strong
Cash Ratio?5.04Strong
Debt/Equity?0.07Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.32CHEAP▾
Peers100
S&P91
P/S?20,267.49HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-6.0CHEAP▾
S&P97
EV/Sales?19,355.68HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-19.4%WEAK▾
S&P8
ROA?-17.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-76562000
Enterprise Value?$600.0M
Fundamentals ratios updated end of day